What are the criteria for diagnosing acute kidney injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Kidney Injury Diagnostic Criteria

Acute kidney injury (AKI) is diagnosed when any one of the following KDIGO criteria is met: serum creatinine increase ≥0.3 mg/dL within 48 hours, OR serum creatinine increase to ≥1.5 times baseline within 7 days, OR urine output <0.5 mL/kg/h for 6 consecutive hours. 1, 2

Core Diagnostic Criteria

The KDIGO classification provides three independent pathways to diagnose AKI—meeting any single criterion is sufficient 1, 2:

  • Serum creatinine increase ≥0.3 mg/dL (≥26.5 μmol/L) within 48 hours 1, 2
  • Serum creatinine increase to ≥1.5 times baseline (≥50% increase) within the prior 7 days 1, 2
  • Urine volume <0.5 mL/kg/h for 6 consecutive hours 1, 2

These criteria were developed by harmonizing the RIFLE and AKIN classifications into a unified framework that captures AKI earlier and more comprehensively 1. Even small creatinine increases of 0.3 mg/dL independently increase hospital mortality approximately fourfold, making early detection critical 2.

Severity Staging

Once AKI is diagnosed, stage the severity to guide prognosis and management 2:

Stage 1:

  • Serum creatinine 1.5-1.9 times baseline OR increase ≥0.3 mg/dL 1, 2
  • Urine output <0.5 mL/kg/h for 6-12 hours 1, 2

Stage 2:

  • Serum creatinine 2.0-2.9 times baseline 1, 2
  • Urine output <0.5 mL/kg/h for ≥12 hours 1, 2

Stage 3:

  • Serum creatinine ≥3.0 times baseline OR increase to ≥4.0 mg/dL (with acute increase ≥0.3 mg/dL) OR initiation of renal replacement therapy 1, 2
  • Urine output <0.3 mL/kg/h for ≥24 hours OR anuria for ≥12 hours 1, 2

Progression through higher AKI stages correlates strongly with increased mortality 2.

Establishing Baseline Creatinine

Use the most recent serum creatinine value from the previous 3 months when available, preferring the value closest to admission time 3, 2. This approach provides the most accurate baseline for detecting acute changes 2.

When no prior creatinine exists, use the admission creatinine as baseline 3. The previously recommended practice of back-calculating baseline using MDRD formula (assuming GFR 75 mL/min/1.73 m²) has been removed from current ICA criteria for cirrhotic patients 3.

Critical Caveats and Pitfalls

Serum Creatinine Limitations

Serum creatinine is a concentration marker affected by multiple non-renal factors 1:

  • Volume expansion dilutes creatinine, potentially masking significant GFR reduction in patients receiving aggressive fluid resuscitation 1
  • Muscle wasting (cirrhosis, malnutrition, elderly) causes falsely low baseline creatinine 4
  • Hyperbilirubinemia interferes with colorimetric creatinine assays, causing inaccurate measurements 4, 2
  • Increased tubular secretion in cirrhosis overestimates actual kidney function 4

Urine Output Criteria—When NOT to Use

In patients with cirrhosis and ascites, rely exclusively on serum creatinine changes and ignore urine output criteria 4, 3, 2. These patients are frequently oliguric with avid sodium retention despite maintaining relatively normal GFR 4, 3. Diuretic therapy further confounds urine output interpretation 4, 2.

The ICA consensus specifically removed urine output from AKI diagnostic criteria in cirrhotic patients because it does not apply to this population 3.

Special Considerations for Cirrhosis

For cirrhotic patients, the ICA modified KDIGO criteria 4, 3:

  • Baseline creatinine can be from the previous 3 months (not just 7 days) 3
  • Urine output criteria are excluded from diagnosis and staging 3
  • Creatinine threshold ≥1.5 mg/dL predicts AKI progression and worse prognosis in this population 4, 3

Algorithmic Approach to Diagnosis

  1. Obtain baseline creatinine: Use most recent value from past 3 months, or admission value if none available 3, 2

  2. Monitor creatinine at 48-hour intervals to detect the 0.3 mg/dL threshold 2—do not wait for creatinine to reach 1.5 mg/dL, as this outdated threshold indicates GFR has already fallen to ~30 mL/min 2

  3. Apply diagnostic criteria: Check if any single criterion is met (0.3 mg/dL rise in 48h, 1.5× baseline in 7 days, or urine output <0.5 mL/kg/h for 6h) 1, 2

  4. Stage the severity using the most severe criterion met 2

  5. Exclude urine output criteria in cirrhotic patients with ascites or those on diuretics 4, 3, 2

  6. Adjust interpretation for volume status—consider adjusting creatinine for volume accumulation in massive fluid resuscitation 1

The KDIGO criteria represent the current standard of care, validated across diverse populations and consistently demonstrating that AKI severity correlates with mortality independent of other clinical factors 1, 2.

Related Questions

Which of the following correctly defines acute kidney injury (AKI) according to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines?
What criteria are commonly followed for Acute Kidney Injury (AKI) diagnosis and staging, specifically the KDIGO (Kidney Disease: Improving Global Outcomes) criteria?
What are the diagnostic criteria for acute kidney injury (AKI)?
What are the diagnostic criteria for Acute Kidney Injury (AKI)?
What are the criteria and initial workup for Acute Kidney Injury (AKI)?
What is the best management approach for an elderly patient with newly diagnosed hyperlipidemia?
Can a 13-year-old patient with advanced asthma be given triple therapy (combination of a corticosteroid, a long-acting beta-agonist (LABA), and a long-acting muscarinic antagonist (LAMA))?
What is the recommended treatment for a patient with impetigo, considering potential allergies to penicillin (Penicillin) and the need for effective management of the infection?
What are the recommended medication doses for a 62-year-old female weighing 55 kg with potential impaired renal function, undergoing a pedicular C-arm (Computed Axial Rotation) guided biopsy, considering ketorolac (Toradol), tramadol (Ultram), sugammadex (Bridion), or Antron (unknown medication) for pain management before extubation?
What is the appropriate evaluation and management for a patient with sudden onset hoarseness of unknown cause?
What is the diagnosis and treatment for a patient with elevated Thyroid-Stimulating Hormone (TSH) levels and normal Free Triiodothyronine (FT3) and Free Thyroxine (FT4) levels, indicating subclinical hypothyroidism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.